U.S. International Trade Commission Updates Investigation on Medical Imaging Devices
Estimated reading time: 1–7 minutes
The U.S. International Trade Commission (ITC) has announced a new update concerning an investigation into certain medical imaging devices. This news is important as it may affect companies involved in the manufacturing and selling of these devices.
The investigation began on February 2, 2026. It was prompted by a complaint from MolecuLight Inc., a company from Toronto, Canada, and MolecuLight Corp., based in Pittsburgh, USA. These companies claim that their U.S. Patent No. 10,438,356 was infringed upon. The patent is related to medical imaging devices.
The companies accuse two organizations of importing and selling these imaging devices in the U.S. The two accused companies are Kent Imaging Inc. from Calgary, Canada, and Adiuvo Diagnostics Pvt. Ltd. from Chennai, India.
The complaint also suggests that the actions of these organizations have affected a domestic industry in the U.S.
On May 8, 2026, MolecuLight filed a motion with the ITC. They wanted to add the University Health Network (UHN) as a co-complainant in the investigation. This means UHN would join MolecuLight in their complaint. The reason for this addition is that UHN owns the patent in question, and their involvement could simplify the legal process. It could also help in the discovery phase, which is when both sides gather information to support their cases.
Neither the responding companies nor the Office of Unfair Import Investigations opposed this motion. This means nobody objected to UHN joining the complaint.
On May 11, 2026, an Administrative Law Judge (ALJ) supported this motion. The ALJ made an “Initial Determination” or ID. In this ID, the Judge said the motion by MolecuLight followed all the rules. The Judge agreed that including UHN as a co-complainant would make things easier, especially during the investigation process.
The ITC has now decided not to review the ALJ’s initial determination. They have officially amended the complaint to include UHN as a co-complainant.
The decision took place on May 22, 2026, and was issued by Sharon Bellamy, a Supervisory Hearings and Information Officer at the ITC.
The ITC has the authority to make this decision under Section 337 of the Tariff Act of 1930. This section deals with unfair practices in importing goods into the United States.
This update is very important for those following the case of the medical imaging devices. It shows the progress being made and the legal steps involved in such investigations.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
